Ms Claire Henry
Tabs
Publications related to this Person
Journal articles
Werner B; Yuwono NL; Henry C; Gunther K; Rapkins RW; Ford CE; Warton K, 2019, 'Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight', PLoS ONE, vol. 14, pp. e0224338, http://dx.doi.org/10.1371/journal.pone.0224338
Cortesi M; Llamosas E; Henry CE; Kumaran RYA; Ng B; Youkhana J; Ford CE, 2018, 'I-AbACUS: A Reliable Software Tool for the Semi-Automatic Analysis of Invasion and Migration Transwell Assays', Scientific Reports, vol. 8, http://dx.doi.org/10.1038/s41598-018-22091-5
Coopes A; Henry CE; Llamosas E; Ford CE, 2018, 'An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target', Endocrine-Related Cancer, vol. 25, pp. R647 - R662, http://dx.doi.org/10.1530/ERC-18-0112
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE, 2018, 'ROR1 and ROR2 play distinct and opposing roles in endometrial cancer', Gynecologic Oncology, vol. 148, pp. 576 - 584, http://dx.doi.org/10.1016/j.ygyno.2018.01.025
Henry CE; Emmanuel C; Lambie N; Loo C; Kan B; Kennedy CJ; de Fazio A; Hacker NF; Ford CE, 2017, 'Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer', Translational Oncology, vol. 10, pp. 346 - 356, http://dx.doi.org/10.1016/j.tranon.2017.01.014
Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2017, 'Validation of specificity of antibodies for immunohistochemistry: the case of ROR2', Virchows Archiv : an international journal of pathology, vol. 470, pp. 99 - 108, http://dx.doi.org/10.1007/s00428-016-2019-5
Henry C; Hacker N; Ford C, 2017, 'Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis', Oncotarget, vol. 8, pp. 112727 - 112738, http://dx.doi.org/10.18632/oncotarget.22559
Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2016, 'Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (Virchows Archiv, (2016), 10.1007/s00428-016-2019-5)', Virchows Archiv, vol. 469, pp. 717, http://dx.doi.org/10.1007/s00428-016-2036-4
Henry C; ford C; hacker N; Djordjevic A; Llamosas E, 2016, 'Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.', Oncogenesis, vol. 5, pp. e226, http://dx.doi.org/10.1038/oncsis.2016.32
Ford CE; Henry C; Llamosas E; Djordjevic A; Hacker N, 2016, 'Wnt signalling in gynaecological cancers: A future target for personalised medicine?', Gynecologic Oncology, vol. 140, pp. 345 - 351, http://dx.doi.org/10.1016/j.ygyno.2015.09.085
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE, 2015, 'Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling', Journal of Cancer Research and Clinical Oncology, vol. 141, pp. 243 - 254, http://dx.doi.org/10.1007/s00432-014-1824-y
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C, 2015, 'Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion', Oncotarget, vol. 6, pp. 40310 - 40326, http://dx.doi.org/10.18632/oncotarget.5643
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V, 2014, 'The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer', Gynecologic Oncology, vol. 134, pp. 338 - 345, http://dx.doi.org/10.1016/j.ygyno.2014.06.004
Conference Presentations
Ford CE; Henry CE; Llamosas E; Djordjevic A; Hacker NF; Heinzelmann-Schwarz VA; Ward RL, 2014, 'HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, pp. 952 - 952, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966501261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Print